Latest News - Acne

Tuesday, March 06, 2018

Differin Launches Retinoid Education Week

Differin® has launched Retinoid Education Week to educate the more than 50 million Americans with acne about how retinoids can be used to treat their condition. Part of Nestlé Skin Health&r…

Read the full story

Thursday, March 01, 2018

Calling All Students: Ortho Dermatologics Now Accepting Applications for the 2018 Aspire Higher Scholarship Program

Ortho Dermatologics is accepting applications for the 2018 Aspire Higher scholarship program for students who have been affected by dermatologic conditions. Through the program, nine students will …

Read the full story

Thursday, February 22, 2018

Vit D Levels Elevated in Acne

Levels of vitamin D are higher in acne patients, compared to age/sex matched controls. Researchers found a significant inverse relation between level of 25 hydroxy vitamin D and severity of acne vulga…

Read the full story

Wednesday, February 07, 2018

Research Finds Acne Linked with Increased Risk of Depression

In an analysis of one of the largest electronic medical records databases in the world, researchers found that patients with acne had a significantly increased risk of developing major depression, but…

Read the full story

Monday, January 22, 2018

Retin-A Micro Gel Microsphere 0.06% Now Available from Ortho Dermatologics to Treat Acne

Retin-A Micro (tretinoin) gel microsphere 0.06% is now available commercially to healthcare professionals. The FDA approved Ortho Dermatologics' Supplemental New Drug Application (sNDA) for Retin-…

Read the full story

Friday, January 12, 2018

FDA Accepts Ortho Dermatologics' Filing for IDP-121 Acne Treatment In Lotion Form

The FDA has accepted  Ortho Dermatologics' New Drug Application for IDP-121 (tretinoin 0.05%) lotion (Altreno) with a PDUFA action date of Aug. 27, 2018. If approved, Altreno will be the firs…

Read the full story

Wednesday, December 20, 2017

FDA Accepts NDA for Allergan, Paratek Acne Drug

The U.S. Food and Drug Administration accepted a New Drug Application (NDA) to review SeysaraTM(sarecycline) for the treatment of moderate to severe acne vulgaris in patients 9 years of age and older,…

Read the full story

Thursday, December 14, 2017

Acne Anxiety Dampens Teen Social Media Use

Teens with acne report a negative impact on their body image and self-esteem, and this translates into anxiety over using social media, mainly the online posting of photos, videos and "…

Read the full story

Wednesday, November 08, 2017

Novan Plans to Complete Development of SB204 Acne Candidate via Third Party Funding and Execution

Novan, Inc., has agreed in principle to a business structure that would enable further development and advancement of SB204 for the treatment of acne vulgaris via third party financing and third party…

Read the full story

Monday, October 23, 2017

Sun Dermatology Launches Absorica Tracker App to Help Patients Track Progress

Sun Pharma launched an Absorica Tracker App to help patients get the most out of their treatment. The easy-to-use interface is designed to help users to monitor their progress with Absorica (isotretin…

Read the full story

Friday, October 20, 2017

Exuviance Introduces New Detox Mud Treatment

Exuviance is rolling out their new Detox Mud Treatment. The Exuviance Detox Mud Treatment is formulated with three key ingredients: 23 percent Active Charcoal, Clay, and NeoGlucosamine® for a r…

Read the full story

Tuesday, September 26, 2017

Novan Has Guidance Meeting with FDA on SB204

Novan, Inc. is eyeing an additional pivotal trial for its investigational treatment for acne vulgaris, SB204. The company concluded a guidance meeting with the FDA regarding SB204 in which t…

Read the full story

Thursday, August 24, 2017

Bioré Skincare Partners with Girl Up

To celebrate the launch of their new Limited Edition Deep Cleansing Pore Strips, Bioré® Skincare is partnering with Girl Up™, a United Nations Foundation campaign. Girl Up mob…

Read the full story

Friday, July 28, 2017

Cutanea Life Sciences Unveils Facing Forward Mobile App for Acne Patients

Cutanea Life Sciences, Inc. introduced its Facing Forward mobile application for patients who are prescribed Aktipak (erythromycin and benzoyl peroxide) Gel, 3%/5%, a combination therapy indicate…

Read the full story

Thursday, July 27, 2017

Valeant’s Newly Minted Ortho Dermatologic Unit Makes Big Splash at Summer AAD

It’s go big or go home for the newly re-branded Valeant Ortho Dermatologic division. At the 2017 American Academy of Dermatology in New York City, the company will officially launch …

Read the full story
Load More